I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A common germline variant in CYP11B1 is associated with adv..:
Stefan A.J. Buck
;
Marinda Meertens
;
Frederiek M.F. van Ooijen
...
http://www.sciencedirect.com/science/article/pii/S0753332223016888. , 2023
Link:
https://doi.org/10.1016/j.biopha.2023.115890
RT Journal T1
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6d3d5ec4ff3b487a8575fbe70cc76c22&Exemplar=1&LAN=DE A1 Stefan A.J. Buck A1 Marinda Meertens A1 Frederiek M.F. van Ooijen A1 Esther Oomen-de Hoop A1 Evert de Jonge A1 Marieke J.H. Coenen A1 Andries M. Bergman A1 Stijn L.W. Koolen A1 Ronald de Wit A1 Alwin D.R. Huitema A1 Ron H.N. van Schaik A1 Ron H.J. Mathijssen PB Elsevier YR 2023 K1 Abiraterone K1 Enzalutamide K1 Germline variant K1 CYP11B1 K1 Prostate cancer K1 Clinical outcome K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S0753332223016888 LK http://dx.doi.org/https://doi.org/10.1016/j.biopha.2023.115890 DO https://doi.org/10.1016/j.biopha.2023.115890 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)